Literature DB >> 2264748

[Natural penicillin resistance of Francisella tularensis].

N V Pavlovich, T I Tkacheva.   

Abstract

Altered viable forms of F. tularensis with spheroplast specific damages of the surface structures were isolated after the culture exposure to lithium chloride (0.5 and 1%). Study of natural penicillin resistance in the spheroplasts and bacterial forms of F. tularensis revealed their difference: the spheroplasts of the strains tested had a lower resistance to beta-lactam antibiotics than the bacterial forms while the activity of spheroplast beta-lactamase did not differ from that of the enzyme of the bacterial form and equalled 224 to 252 U/ml of the cell suspension. Therefore, on the model of the lithium-induced spheroplasts it appeared possible to show that the damages of the surface structures of the cell walls of F. tularensis changed the penicillin resistance level which was indicative of involvement of the F. tularensis cell walls in the phenomenon of the natural resistance to beta-lactams.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2264748

Source DB:  PubMed          Journal:  Antibiot Khimioter        ISSN: 0235-2990


  3 in total

1.  Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model.

Authors:  Nina Tsao; Chih-Feng Kuo; Ching-Chen Chiu; Wei-Chen Lin; Wan-Hui Huang; Li-Yang Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

2.  Characterization of two unusual clinically significant Francisella strains.

Authors:  J E Clarridge; T J Raich; A Sjösted; G Sandström; R O Darouiche; R M Shawar; P R Georghiou; C Osting; L Vo
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.

Authors:  Ping Zhang; Jenny Katz; Suzanne M Michalek
Journal:  Mol Immunol       Date:  2008-10-17       Impact factor: 4.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.